Madhuvanthi Vijayan

Madhuvanthi Vijayan, Ph.D., currently serves as a Research Scientist II at Asklepios BioPharmaceutical, Inc. since August 2023. Prior experience includes a Postdoctoral Associate position at Duke University from July 2017 to January 2021, where research focused on the immunogenicity of AAV vectors in gene therapy and host proteins involved in antiviral innate immunity during positive strand RNA virus infections. Additionally, experience as a Senior Research Specialist at the University of Missouri-Columbia from August 2010 to May 2017 involved studying the innate immune response to pathogenic Influenza virus, alongside doctoral studies that characterized the role of sphingolipids in viral infections. Education includes a Ph.D. in Medical Microbiology (Viral Immunology) from Duke University and a B.Tech in Biotechnology from Rajalakshmi Engineering College.